FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

$1,513 vol

ALL

Chance

Full Approval

78%

Full Approval

78%

No Decision

6%

▼ 3

No Decision

6%

▼ 3

Denied (CRL Issued)

7%

Denied (CRL Issued)

7%

2 more

Market Rules

Full Approval

If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Full Approval before Aug 1, 2026, the market resolves to Yes. Outcome verified from AppliedXL.

Note: this event is mutually exclusive.

Timeline and payout

Market openJun 9, 2026 · 6:30pm EDT

Market closesAfter the outcome occurs

Projected payout30 minutes after closing

This market will close early if the FDA issues a decision on Gedatolisib before Aug 1, 2026 Otherwise, it closes by Jul 31, 2026 at 11:59pm EDT.

SeriesKXGEDATOLISIB

EventKXGEDATOLISIB-26

MarketKXGEDATOLISIB-26-FA

Insider trading is prohibited

The following are prohibited from trading this contract:

Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.